Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 1,120,518 | 1,093,289 | 1,036,484 | 1,068,913 | 1,092,964 |
| Cost of Goods | 93,486 | 90,721 | 98,197 | 101,161 | 107,493 |
| Gross Profit | 1,027,032 | 1,002,568 | 938,287 | 967,752 | 985,471 |
| Operating Expenses | 643,340 | 780,375 | 633,526 | 642,953 | 640,114 |
| Operating Income | 384,178 | 222,914 | 304,958 | 324,960 | 345,850 |
| Other Income | 9,360 | 14,680 | 6,846 | -33,077 | -23,713 |
| Pre-tax Income | 393,538 | 237,594 | 311,804 | 291,883 | 322,137 |
| Income Tax | 113,936 | 92,709 | 65,225 | 83,456 | 114,337 |
| Net Income Continuous | 279,602 | 144,885 | 246,579 | 208,427 | 207,800 |
| Minority Interests | 1,939 | 2,040 | 2,592 | 1,773 | 1,012 |
| Net Income | $277,663 | $142,845 | $243,987 | $206,654 | $206,788 |
| EPS Basic Total Ops | 0.96 | 0.49 | 0.85 | 0.70 | 0.71 |
| EPS Basic Continuous Ops | 0.97 | 0.50 | 0.86 | 0.71 | 0.71 |
| EPS Diluted Total Ops | 0.95 | 0.49 | 0.84 | 0.71 | 0.70 |
| EPS Diluted Continuous Ops | 0.96 | 0.50 | 0.85 | 0.71 | 0.71 |
| EBITDA(a) | $470,062 | $349,645 | $427,104 | $446,977 | $473,421 |